Literature DB >> 27466482

In Vivo Isolation of a Highly-aggressive Variant of Triple-negative Human Breast Cancer MDA-MB-231 Using Serial Orthotopic Transplantation.

Shuya Yano1, Kiyoto Takehara1, Shinji Miwa2, Hiroyuki Kishimoto3, Hiroshi Tazawa4, Yasuo Urata5, Shunsuke Kagawa3, Michael Bouvet6, Toshiyoshi Fujiwara3, Robert M Hoffman7.   

Abstract

AIM: We describe the development of a highly-invasive, triple-negative breast cancer (TNBC) variant using serial orthotopic implantation of MDA-MB-231 human breast cancer in nude mice.
MATERIALS AND METHODS: MDA-MB-231 cells expressing red fluorescent protein (RFP) (1×10(7) cells/site) were initially injected subcutaneously in the flank of nude mice. After the subcutaneous tumors grew, they were harvested and cut into small pieces for orthotopic implantation in the right lower mammary gland. After the orthotopic tumors grew, they were resected and cut into small pieces and orthotopically re-implanted into the mammary gland of nude mice. The tumors grew and metastasized to lymph nodes. The lymph node metastases were harvested and cut into small pieces and orthotopically re-implanted into the mammary gland of nude mice. After the orthotopic tumors grew, the tumor was removed leaving residual cancer cells, which grew and metastasized to lymph nodes. The lymph node metastases were harvested, cut into pieces and orthotopically re-implanted into the mammary gland of nude mice for two cycles and then isolated.
RESULTS: The isolated variant is highly invasive in the mammary gland and metastasized to lymph nodes in 10 of 12 mice compared to 2 of 12 of the parental cell line.
CONCLUSION: The availability of a highly invasive variant of TNBC targeting lymph nodes will be very useful for drug discovery of TNBC, a recalcitrant cancer and for mechanistic studies of its aggressiveness. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Breast cancer; MDA-MB-231; high metastasis variant; in vivo selection; lymph node; metastasis; nude mice; orthothopic transplantation; red fluorescent protein (RFP); triple negative

Mesh:

Year:  2016        PMID: 27466482

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  GFP labeling kinetics of triple-negative human breast cancer by a killer-reporter adenovirus in 3D Gelfoam® histoculture.

Authors:  Shuya Yano; Kiyoto Takehara; Shinji Miwa; Hiroyuki Kishimoto; Hiroshi Tazawa; Yasuo Urata; Shunsuke Kagawa; Michael Bouvet; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-02-23       Impact factor: 2.416

2.  High-metastatic triple-negative breast-cancer variants selected in vivo become chemoresistant in vitro.

Authors:  Shuya Yano; Kiyoto Takehara; Hiroyuki Kishimoto; Hiroshi Tazawa; Yasuo Urata; Shunsuke Kagawa; Michael Bouvet; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2017-01-26       Impact factor: 2.416

3.  Comparison of in vitro invasiveness of high- and low-metastatic triple-negative human breast cancer visualized by color-coded imaging.

Authors:  Shuya Yano; Kiyoto Takehara; Hiroshi Tazawa; Hiroyuki Kishimoto; Shunsuke Kagawa; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-10-24       Impact factor: 2.416

4.  Tumor-targeting adenovirus OBP-401 inhibits primary and metastatic tumor growth of triple-negative breast cancer in orthotopic nude-mouse models.

Authors:  Shuya Yano; Kiyoto Takehara; Hiroyuki Kishimoto; Hiroshi Tazawa; Yasuo Urata; Shunsuke Kagawa; Michael Bouvet; Toshiyoshi Fujiwara; Robert M Hoffman
Journal:  Oncotarget       Date:  2016-12-20

5.  Deletion of sorting nexin 27 suppresses proliferation in highly aggressive breast cancer MDA-MB-231 cells in vitro and in vivo.

Authors:  Jilei Zhang; Kendy Li; Yongguo Zhang; Rong Lu; Shaoping Wu; Jingrong Tang; Yinglin Xia; Jun Sun
Journal:  BMC Cancer       Date:  2019-06-10       Impact factor: 4.430

Review 6.  The In Vivo Selection Method in Breast Cancer Metastasis.

Authors:  Jun Nakayama; Yuxuan Han; Yuka Kuroiwa; Kazushi Azuma; Yusuke Yamamoto; Kentaro Semba
Journal:  Int J Mol Sci       Date:  2021-02-14       Impact factor: 5.923

7.  tRNA Queuosine Modification Enzyme Modulates the Growth and Microbiome Recruitment to Breast Tumors.

Authors:  Jilei Zhang; Rong Lu; Yongguo Zhang; Żaneta Matuszek; Wen Zhang; Yinglin Xia; Tao Pan; Jun Sun
Journal:  Cancers (Basel)       Date:  2020-03-09       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.